|
US4853221A
(en)
|
1980-11-13 |
1989-08-01 |
Warner-Lambert Company |
Method for treating non-small cell lung cancer, head and neck cancers and breast cancer
|
|
US4801575A
(en)
|
1986-07-30 |
1989-01-31 |
The Regents Of The University Of California |
Chimeric peptides for neuropeptide delivery through the blood-brain barrier
|
|
US5035878A
(en)
|
1988-09-12 |
1991-07-30 |
University Of Rochester |
Use of dithiocarbamates to counteract myelosuppression
|
|
US5294430A
(en)
|
1988-09-12 |
1994-03-15 |
University Of Rochester |
Use of dithiocarbamates to treat myelosuppression
|
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
|
US5597798A
(en)
|
1990-03-05 |
1997-01-28 |
The Regents Of The University Of California |
Taxol and epidermal growth factor used to enhance treatment of ovarian cancer
|
|
ES2187500T3
(es)
|
1991-02-21 |
2003-06-16 |
Smithkline Beecham Corp |
Uso de topotecano en el tratamiento del carcinoma pulmonar no de celulas pequeñas.
|
|
US6287792B1
(en)
|
1991-06-17 |
2001-09-11 |
The Regents Of The University Of California |
Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology
|
|
US5795870A
(en)
|
1991-12-13 |
1998-08-18 |
Trustees Of Princeton University |
Compositions and methods for cell transformation
|
|
KR970702725A
(ko)
|
1994-04-26 |
1997-06-10 |
노부히로 나리따 |
비소세포 폐암 치료용 의약 조성물(Medicinal Composition as a Remedy for Nonsmall Cell Lung Cancer)
|
|
US6011069A
(en)
|
1995-12-26 |
2000-01-04 |
Nisshin Flour Milling Co., Ltd. |
Multidrug resistance inhibitors
|
|
US5998402A
(en)
|
1996-04-19 |
1999-12-07 |
American Home Products Corporation |
2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indoles as estrogenic agents
|
|
US6733966B1
(en)
|
1997-06-04 |
2004-05-11 |
Rijksuniversiteit Te Leiden |
Diagnostic test kit for determining a predisposition for breast and ovarian cancer, materials and methods for such determination
|
|
US6335156B1
(en)
|
1997-12-18 |
2002-01-01 |
The Johns Hopkins University School Of Medicine |
14-3-3σ arrests the cell cycle
|
|
EP1085846A2
(en)
|
1998-06-08 |
2001-03-28 |
Advanced Medicine, Inc. |
Multibinding inhibitors of microsomal triglyceride transferase protein
|
|
WO2000002555A1
(en)
|
1998-07-09 |
2000-01-20 |
Nardella Francis A |
Methods and compositions for the treatment of chronic lymphocytic leukemia
|
|
AU6607100A
(en)
|
1999-07-23 |
2001-02-13 |
Regents Of The University Of California, The |
Anti-growth factor receptor avidin fusion proteins as universal vectors for drugdelivery
|
|
US6635677B2
(en)
|
1999-08-13 |
2003-10-21 |
Case Western Reserve University |
Methoxyamine combinations in the treatment of cancer
|
|
US6372250B1
(en)
|
2000-04-25 |
2002-04-16 |
The Regents Of The University Of California |
Non-invasive gene targeting to the brain
|
|
US20020037328A1
(en)
*
|
2000-06-01 |
2002-03-28 |
Brown Dennis M. |
Hexitol compositions and uses thereof
|
|
GB0014820D0
(en)
|
2000-06-16 |
2000-08-09 |
Medical Res Council |
Methods and materials relating to plasmid vectors
|
|
ITMI20002358A1
(it)
|
2000-10-31 |
2002-05-01 |
Flavio Moroni |
Derivati di tieno ,2, 3-c|isochinolin-3-one come inibitori della poli(a dp-ribosio)polimerasi
|
|
US7619005B2
(en)
|
2000-11-01 |
2009-11-17 |
Cognition Pharmaceuticals Llc |
Methods for treating cognitive impairment in humans with Multiple Sclerosis
|
|
WO2003000012A2
(en)
|
2001-06-21 |
2003-01-03 |
Millennium Pharmaceuticals, Inc. |
Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast and ovarian cancer
|
|
DE60329126D1
(de)
|
2002-02-20 |
2009-10-15 |
Beth Israel Hospital |
Konjugate mit biologisch abbaubarem polymer und verwendung dafür
|
|
EP1654377A4
(en)
|
2002-03-01 |
2010-03-24 |
Roger Williams Hospital |
PROCESSES AND COMPOSITIONS RELATED TO THE SHC PROTEIN FOR THE PROGNOSIS OF BREAST, PROSTATE AND EGG CANCER
|
|
AU2003223482A1
(en)
|
2002-04-11 |
2003-10-27 |
Zymogenetics, Inc. |
Use of interleukin-24 to treat ovarian cancer
|
|
IL164218A0
(en)
|
2002-04-11 |
2005-12-18 |
Zymogenetics Inc |
Use of interleukin-19 to treat ovarian cancer
|
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
|
US7968569B2
(en)
|
2002-05-17 |
2011-06-28 |
Celgene Corporation |
Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
|
|
US7388079B2
(en)
|
2002-11-27 |
2008-06-17 |
The Regents Of The University Of California |
Delivery of pharmaceutical agents via the human insulin receptor
|
|
US20060058217A1
(en)
|
2003-01-21 |
2006-03-16 |
White Hillary D |
Compositions and methods for treatment of ovarian cancer
|
|
WO2004085505A2
(en)
|
2003-03-24 |
2004-10-07 |
Sequoia Pharmaceuticals, Inc. |
Long acting biologically active conjugates
|
|
ZA200507752B
(en)
|
2003-03-28 |
2007-01-31 |
Threshold Pharmaceuticals Inc |
Compositions and methods for treating cancer
|
|
EP3178816A1
(en)
|
2003-04-11 |
2017-06-14 |
PTC Therapeutics, Inc. |
1,2,4-oxadiazole benzoic acid compound and its use for nonsense suppression and the treatment of disease
|
|
MXPA06002499A
(es)
|
2003-09-04 |
2006-06-20 |
Aventis Pharma Inc |
Indoles sustituidos como inhibidores de poli (adp-ribosa) polimerasa (parp).
|
|
CA2540289A1
(en)
|
2003-10-02 |
2005-04-14 |
Cephalon, Inc. |
Substituted indole derivatives
|
|
HUP0303313A2
(hu)
|
2003-10-09 |
2005-07-28 |
Richter Gedeon Vegyészeti Gyár Rt. |
Transzdermális gyógyszerkészítmények
|
|
CA2545942C
(en)
|
2003-11-14 |
2012-07-10 |
Lorus Therapeutics Inc. |
Aryl imidazoles and their use as anti-cancer agents
|
|
WO2005087724A2
(en)
|
2004-03-11 |
2005-09-22 |
Altana Pharma Ag |
Sulphonylpyrroles as hdac inhibitors
|
|
WO2005099824A1
(en)
|
2004-03-30 |
2005-10-27 |
Synta Pharmaceuticals, Corp. |
1-glyoxylamide indolizines for treating lung and ovarian cancer
|
|
WO2005098446A2
(en)
|
2004-03-31 |
2005-10-20 |
The Johns Hopkins University |
Biomarkers for ovarian cancer
|
|
US8957056B2
(en)
|
2004-05-25 |
2015-02-17 |
Sloan-Kettering Instiute For Cancer Research |
Migrastatin analogs in the treatment of cancer
|
|
ATE540936T1
(de)
|
2004-06-30 |
2012-01-15 |
Janssen Pharmaceutica Nv |
Substituierte 2-alkyl-chinazolinonderivate als parp-hemmer
|
|
LT2311874T
(lt)
|
2004-07-22 |
2017-11-27 |
Erasmus University Medical Center Rotterdam |
Rišančiosios molekulės
|
|
ES2406605T3
(es)
|
2004-08-20 |
2013-06-07 |
Buck Institute For Age Research |
Moléculas pequeñas que sustituyen o agonizan la función p53
|
|
US8969379B2
(en)
|
2004-09-17 |
2015-03-03 |
Eisai R&D Management Co., Ltd. |
Pharmaceutical compositions of 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7=methoxy-6-quinolinecarboxide
|
|
US8080675B2
(en)
|
2004-09-21 |
2011-12-20 |
Marshall Edwards, Inc. |
Chroman derivatives, medicaments and use in therapy
|
|
EP1824821A2
(en)
|
2004-11-23 |
2007-08-29 |
PTC Therapeutics, Inc. |
Carbazole, carboline and indole derivatives useful in the inhibition of vegf production
|
|
SI1827437T1
(sl)
|
2004-12-15 |
2012-02-29 |
Sigma Tau Ind Farmaceuti |
Kombinacije terapevtskih sredstev za zdravljenje raka
|
|
US7820668B2
(en)
|
2005-01-19 |
2010-10-26 |
Eisai Inc. |
Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP
|
|
US8404829B2
(en)
|
2005-01-25 |
2013-03-26 |
The Regents Of The University Of California |
Predictive and therapeutic markers in ovarian cancer
|
|
EP1702989A1
(en)
|
2005-03-16 |
2006-09-20 |
Fundacion para la Investigacion Clinica y Molecular del Cancer de Pulmon |
Method of predicting the clinical response to cisplatin or carboplatin chemotherapeutic treatment
|
|
WO2006110683A1
(en)
|
2005-04-11 |
2006-10-19 |
Abbott Laboratories |
2-substituted-1h-benzimidazole-4-carboxamides are parp inhibitors
|
|
CA2763671A1
(en)
|
2005-04-26 |
2006-11-02 |
Pfizer Inc. |
P-cadherin antibodies
|
|
AR053272A1
(es)
|
2005-05-11 |
2007-04-25 |
Hoffmann La Roche |
Determinacion de responsivos a la quimioterapia
|
|
MX2007016248A
(es)
|
2005-06-15 |
2008-03-07 |
Cardiome Pharma Corp |
Procedimiento sintetico para la preparacion de compuestos de eter aminociclohexilico.
|
|
US8465929B2
(en)
|
2005-06-24 |
2013-06-18 |
Vermillion, Inc. |
Biomarkers for ovarian cancer
|
|
JP2009501235A
(ja)
*
|
2005-07-15 |
2009-01-15 |
シェーリング コーポレイション |
癌処置において有用なキナゾリン誘導体
|
|
WO2007013946A2
(en)
|
2005-07-20 |
2007-02-01 |
University Of South Florida |
Method of predicting responsiveness to chemotherapy and selecting treatments
|
|
US8101799B2
(en)
|
2005-07-21 |
2012-01-24 |
Ardea Biosciences |
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
|
|
AU2006279794B2
(en)
|
2005-08-12 |
2011-04-07 |
Synta Pharmaceuticals Corp. |
Pyrazole compounds that modulate HSP90 activity
|
|
US7507536B2
(en)
|
2005-10-07 |
2009-03-24 |
The Johns Hopkins University |
Methylation markers for diagnosis and treatment of ovarian cancer
|
|
US8124095B2
(en)
|
2005-10-07 |
2012-02-28 |
Armagen Technologies, Inc. |
Fusion proteins for delivery of erythropoietin to the CNS
|
|
US20090118271A1
(en)
|
2005-10-19 |
2009-05-07 |
Chugai Seiyaku Kabushiki Kaisha |
Preventive or Therapeutic Agents for Pancreatic Cancer, Ovarian Cancer, or Liver Cancer Comprising a Novel Water-Soluble Prodrug
|
|
WO2007050599A2
(en)
|
2005-10-27 |
2007-05-03 |
The Brigham & Women's Hospital, Inc. |
Ginkgolides in the treatment and prevention of ovarian cancer
|
|
EP3173084B1
(en)
|
2005-11-11 |
2019-10-23 |
Boehringer Ingelheim International GmbH |
Quinazoline derivatives for the treatment of cancer diseases
|
|
CN101365473B
(zh)
|
2005-11-16 |
2013-04-03 |
潘塔希生物科学股份有限公司 |
用于治疗或预防卵巢癌的药物组合物
|
|
ES2540561T3
(es)
|
2005-12-20 |
2015-07-10 |
Incyte Corporation |
N-hidroxiamidinoheterociclos como moduladores de indolamina 2,3-dioxigenasa
|
|
JP5324922B2
(ja)
|
2005-12-23 |
2013-10-23 |
エコバイオティクス リミテッド |
スピロケタール
|
|
EP1986625B1
(en)
|
2006-02-10 |
2012-08-01 |
Ramot at Tel-Aviv University Ltd. |
Treatment of ovarian cancer
|
|
PL2001892T3
(pl)
|
2006-03-17 |
2013-09-30 |
Ambit Biosciences Corp |
Imidazolotiazolowe związki do leczenia chorób proliferacyjnych
|
|
PT2024372E
(pt)
|
2006-04-26 |
2010-09-16 |
Hoffmann La Roche |
Derivado de tieno[3,2-d]pirimidina útil como inibidor de pi3k
|
|
IL282783B2
(en)
|
2006-05-18 |
2023-09-01 |
Caris Mpi Inc |
A system and method for determining a personalized medical intervention for a disease stage
|
|
US8768629B2
(en)
|
2009-02-11 |
2014-07-01 |
Caris Mpi, Inc. |
Molecular profiling of tumors
|
|
WO2007139951A2
(en)
|
2006-05-25 |
2007-12-06 |
Synta Pharmaceuticals Corp. |
Method for treating proliferative disorders associated with protooncogene products
|
|
US8318790B2
(en)
|
2006-05-25 |
2012-11-27 |
Synta Pharmaceuticals Corp. |
Triazole compounds that modulate HSP90 activity
|
|
ES2559679T3
(es)
|
2006-06-20 |
2016-02-15 |
Abbvie Inc. |
Pirazoloquinazolinonas como inhibidores de PARP
|
|
BRPI0719123A2
(pt)
|
2006-09-01 |
2013-12-17 |
Cylene Pharmaceuticals Inc |
Moduladores de serina-treonina proteína cinase e parp
|
|
US7547781B2
(en)
|
2006-09-11 |
2009-06-16 |
Curis, Inc. |
Quinazoline based EGFR inhibitors containing a zinc binding moiety
|
|
US8277807B2
(en)
|
2006-10-12 |
2012-10-02 |
Astex Therapeutics Limited |
Pharmaceutical combinations
|
|
UY30639A1
(es)
|
2006-10-17 |
2008-05-31 |
Kudos Pharm Ltd |
Derivados sustituidos de 2h-ftalazin-1-ona, sus formas cristalinas, proceso de preparacion y aplicaciones
|
|
NZ577798A
(en)
|
2006-12-21 |
2012-04-27 |
Vertex Pharma |
5-cyano-4- (pyrrolo [2, 3b] pyridine-3-yl) -pyrimidine derivatives useful as protein kinase inhibitors
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
EP2114983B8
(en)
|
2007-02-07 |
2015-02-18 |
The Regents of the University of Colorado, A Body Corporate |
Axl tyrosine kinase inhibitors and methods of making and using the same
|
|
SI2716301T1
(sl)
|
2007-02-16 |
2017-07-31 |
Merrimack Pharmaceuticals, Inc. |
Protitelesa proti ErbB3 in uporaba le-teh
|
|
KR20090115879A
(ko)
|
2007-02-28 |
2009-11-09 |
이노텍 파마슈티컬스 코포레이션 |
인데노이소퀴놀리논 유사체와 이의 이용 방법
|
|
ES2477497T3
(es)
|
2007-03-02 |
2014-07-17 |
Genentech, Inc. |
Predicción de la respuesta a un inhibidor de la dimerización de HER basado en la expresión de HER3 bajo
|
|
CA2678248C
(en)
|
2007-03-08 |
2016-06-28 |
Janssen Pharmaceutica Nv |
Quinolinone derivatives as parp and tank inhibitors
|
|
US8030060B2
(en)
|
2007-03-22 |
2011-10-04 |
West Virginia University |
Gene signature for diagnosis and prognosis of breast cancer and ovarian cancer
|
|
ES2534573T3
(es)
|
2007-04-06 |
2015-04-24 |
Neurocrine Biosciences, Inc. |
Antagonistas del receptor de la hormona liberadora de gonadotropina y métodos relacionados con los mismos
|
|
TWI448284B
(zh)
|
2007-04-24 |
2014-08-11 |
Theravance Inc |
雙效抗高血壓劑
|
|
JP2008295328A
(ja)
|
2007-05-30 |
2008-12-11 |
Fujifilm Corp |
卵巣癌の検出方法、及び抑制方法
|
|
RU2470017C2
(ru)
|
2007-06-08 |
2012-12-20 |
Янссен Фармацевтика Н.В. |
Производные пиперидина/пиперазина
|
|
US8664358B2
(en)
|
2007-06-29 |
2014-03-04 |
Vermillion, Inc. |
Predictive markers for ovarian cancer
|
|
WO2009016565A1
(en)
|
2007-07-27 |
2009-02-05 |
Piramal Life Sciences Limited |
Tricyclic compounds for the treatment of inflammatory disorders
|
|
SA08290475B1
(ar)
|
2007-08-02 |
2013-06-22 |
Targacept Inc |
(2s، 3r)-n-(2-((3-بيردينيل)ميثيل)-1-آزا بيسيكلو[2، 2، 2]أوكت-3-يل)بنزو فيوران-2-كربوكساميد، وصور أملاحه الجديدة وطرق استخدامه
|
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
AU2008287831B2
(en)
|
2007-08-10 |
2013-05-23 |
Mitsubishi Tanabe Pharma Corporation |
Novel salt of isoquinoline compound and crystal thereof
|
|
CN101802226A
(zh)
|
2007-09-17 |
2010-08-11 |
皇家飞利浦电子股份有限公司 |
分析卵巢癌病症的方法
|
|
DK2209375T3
(da)
|
2007-10-03 |
2014-10-06 |
Eisai Inc |
Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf
|
|
JO2778B1
(en)
|
2007-10-16 |
2014-03-15 |
ايساي انك |
Certain Compounds, Compositions and Methods
|
|
CN101909630A
(zh)
|
2007-11-02 |
2010-12-08 |
新加坡科技研究局 |
预防和治疗肿瘤的方法和化合物
|
|
IL187247A0
(en)
|
2007-11-08 |
2008-12-29 |
Hadasit Med Res Service |
Novel synthetic analogs of sphingolipids
|
|
NZ586123A
(en)
|
2007-11-12 |
2012-12-21 |
Bipar Sciences Inc |
Treatment of ovarian cancer with 4-iodo-3-nitrobenzamide in combination with topoisomerase inhibitors
|
|
US20090170842A1
(en)
|
2007-11-14 |
2009-07-02 |
University Of Kansas |
Brca1-based breast or ovarian cancer prevention agents and methods of use
|
|
ES2524787T3
(es)
|
2007-11-15 |
2014-12-12 |
Msd Italia S.R.L. |
Derivados de piridazinona como inhibidores de PARP
|
|
EP2222345B1
(en)
|
2007-11-23 |
2016-03-23 |
British Columbia Cancer Agency Branch |
Methods for detecting lung cancer and monitoring treatment response
|
|
EP2227691B1
(en)
|
2007-12-05 |
2012-10-31 |
The Wistar Institute Of Anatomy And Biology |
Method for diagnosing lung cancers using gene expression profiles in peripheral blood mononuclear cells
|
|
WO2009071660A1
(en)
|
2007-12-06 |
2009-06-11 |
Novartis Forschungsstiftung, Zweigniederlassung |
Use of protease nexin 1 inhibitors to reduce metastasis
|
|
US8741889B2
(en)
|
2008-01-11 |
2014-06-03 |
Hoffmann-La Roche Inc |
Method of treating non-small cell lung cancer and colon cancer with gamma-secretase inhibitor
|
|
CA2711759A1
(en)
|
2008-01-30 |
2009-08-06 |
Genentech, Inc. |
Pyrazolopyrimidine pi3k inhibitor compounds and methods of use
|
|
US8642347B2
(en)
|
2008-01-31 |
2014-02-04 |
The Brigham And Women's Hospital, Inc. |
Urinary CA125 peptides as biomarkers of ovarian cancer
|
|
CN101998959B
(zh)
|
2008-02-06 |
2013-08-28 |
生物马林药物股份有限公司 |
聚(adp-核糖)聚合酶(parp)的苯并噁唑甲酰胺抑制剂
|
|
CN104474529A
(zh)
|
2008-02-08 |
2015-04-01 |
爱勒让治疗公司 |
治疗性的拟肽大环化合物
|
|
CA2714521A1
(en)
|
2008-02-14 |
2009-08-20 |
Decode Genetics Ehf |
Susceptibility variants for lung cancer
|
|
PL2254570T3
(pl)
|
2008-02-20 |
2014-05-30 |
Actelion Pharmaceuticals Ltd |
Połączenie zawierające paklitaksel do leczenia raka jajnika
|
|
FR2928151B1
(fr)
|
2008-03-03 |
2010-12-31 |
Sanofi Aventis |
Derives platine-carbene n-heterocyclique, leur preparation et leur application en therapeutique
|
|
PT2947072T
(pt)
|
2008-03-17 |
2016-12-06 |
Ambit Biosciences Corp |
1-(3-(6,7-dimetoxiquinazolin-4-iloxi)fenil)-3-(5-(1,1,1-trifluoro-2-metilpropan-2-il)isoxazol-3-il)ureia como modulador da cinase raf no tratamento de doenças oncológicas
|
|
WO2009145815A2
(en)
|
2008-04-01 |
2009-12-03 |
The Brigham And Women's Hospital, Inc. |
Biomarkers of ovarian cancer
|
|
AU2009236256B9
(en)
|
2008-04-14 |
2015-09-24 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Small molecule inhibitors of the pleckstrin homology domain and methods for using same
|
|
WO2009127619A1
(en)
|
2008-04-16 |
2009-10-22 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
|
|
AR071717A1
(es)
|
2008-05-13 |
2010-07-07 |
Array Biopharma Inc |
Pirrolo[2,3-b]piridinas inhibidoras de quinasas chk1 y chk2,composiciones farmaceuticas que las contienen,proceso para prepararlas y uso de las mismas en el tratamiento y prevencion del cancer.
|
|
EP2288741B1
(en)
|
2008-05-14 |
2015-01-28 |
University Health Network |
Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy
|
|
TW201512199A
(zh)
|
2008-06-11 |
2015-04-01 |
Genentech Inc |
二氮雜咔唑及使用方法
|
|
PT2328888E
(pt)
|
2008-07-09 |
2013-01-29 |
Rigel Pharmaceuticals Inc |
Triazóis bicíclicos em ponte substituídos com heteroarilos úteis como inibidores axl
|
|
US8946239B2
(en)
|
2008-07-10 |
2015-02-03 |
Duquesne University Of The Holy Spirit |
Substituted pyrrolo, -furano, and cyclopentylpyrimidines having antimitotic and/or antitumor activity and methods of use thereof
|
|
US8338477B2
(en)
|
2008-07-11 |
2012-12-25 |
Neumedics |
Tetracycline derivatives with reduced antibiotic activity and neuroprotective benefits
|
|
SG193842A1
(en)
|
2008-08-06 |
2013-10-30 |
Biomarin Pharm Inc |
Dihydropyridophthalazinone inhibitors of poly(adp-ribose)polymerase (parp)
|
|
TW201011003A
(en)
|
2008-08-08 |
2010-03-16 |
Synta Pharmaceuticals Corp |
Triazole compounds that modulate HSP90 activity
|
|
NZ591137A
(en)
|
2008-08-15 |
2012-10-26 |
Merrimack Pharmaceuticals Inc |
Methods and systems for predicting response of cells to a therapeutic agent
|
|
BRPI0917791B1
(pt)
|
2008-08-22 |
2022-03-22 |
Novartis Ag |
Compostos de pirrolopirimidina como inibidores de cdk, bem como composição farmacêutica e combinação
|
|
EP2166008A1
(en)
|
2008-09-23 |
2010-03-24 |
Genkyo Tex Sa |
Pyrazolo pyridine derivatives as NADPH oxidase inhibitors
|
|
KR100961410B1
(ko)
|
2008-10-14 |
2010-06-09 |
(주)네오팜 |
단백질 키나제 억제제로서 헤테로사이클릭 화합물
|
|
GB0819095D0
(en)
|
2008-10-17 |
2008-11-26 |
Spirogen Ltd |
Pyrrolobenzodiazepines
|
|
US8946275B2
(en)
|
2008-10-21 |
2015-02-03 |
Threshold Pharmaceuticals, Inc. |
Treatment of cancer using hypoxia activated prodrugs
|
|
WO2010059858A1
(en)
|
2008-11-19 |
2010-05-27 |
Duke University |
Manassantin compounds and methods of making and using same
|
|
PT2370442E
(pt)
|
2008-11-26 |
2013-06-27 |
Pfizer |
3-aminociclopentanocarboxamidas como moduladores de receptor de quimiocina
|
|
US20100160322A1
(en)
|
2008-12-04 |
2010-06-24 |
Abbott Laboratories |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
|
|
US8058075B2
(en)
|
2008-12-10 |
2011-11-15 |
University Of Utah Research Foundation |
Molecular fluorescence sensor for highly sensitive and selective detection of mercury
|
|
JP5368579B2
(ja)
|
2008-12-22 |
2013-12-18 |
エフ．ホフマン−ラ ロシュ アーゲー |
癌のマーカーとしてのａｒｍｅｔ
|
|
MY152386A
(en)
|
2009-01-23 |
2014-09-15 |
Takeda Pharmaceutical |
Substituted 6a,7,8,9-tetrahydropyrido[3,2-e] pyrrolo[1,2-a]pyrazin-6(5h)-ones
|
|
US8492361B2
(en)
|
2009-02-10 |
2013-07-23 |
Celgene Corporation |
Methods for treating non-small cell lung cancer using 5-azacytidine
|
|
US8648046B2
(en)
|
2009-02-26 |
2014-02-11 |
Oncolix, Inc. |
Compositions and methods for visualizing and eliminating cancer stem cells
|
|
CN105601619A
(zh)
|
2009-02-27 |
2016-05-25 |
埃姆比特生物科学公司 |
调控jak激酶的喹唑啉衍生物和其使用方法
|
|
US8969001B2
(en)
|
2009-03-12 |
2015-03-03 |
Rush University Medical Center |
Materials and methods for predicting recurrence of non-small cell lung cancer
|
|
CN101869558A
(zh)
*
|
2009-04-22 |
2010-10-27 |
北京大学 |
二乙酰二脱水卫矛醇的抗血管生成及肿瘤转移作用
|
|
PT104607B
(pt)
|
2009-05-20 |
2012-03-23 |
Univ De Coimbra |
Derivados triterpenóides úteis como agentes antiproliferativos
|
|
US8546413B2
(en)
|
2009-06-15 |
2013-10-01 |
Nerviano Medical Sciences S.R.L. |
Substituted pyrimidinylpyrrolopyridinone derivatives, process for their preparation and their use as kinase inhibitors
|
|
US8980268B2
(en)
|
2009-07-29 |
2015-03-17 |
Regeneron Pharamceuticals, Inc. |
Methods for treating cancer by administering an anti-Ang-2 antibody
|
|
JP5715625B2
(ja)
|
2009-07-30 |
2015-05-07 |
武田薬品工業株式会社 |
ポリ（ａｄｐ−リボース）ポリメラーゼ（ｐａｒｐ）阻害剤
|
|
EP2460005A4
(en)
|
2009-07-31 |
2012-11-21 |
Translational Genomics Res Inst |
METHOD FOR ASSESSING A CANCER PROGRESSION RISK
|
|
WO2011024873A1
(ja)
|
2009-08-26 |
2011-03-03 |
武田薬品工業株式会社 |
縮合複素環誘導体およびその用途
|
|
US20130203861A1
(en)
|
2009-09-09 |
2013-08-08 |
Golden Biotechnology Corporation |
Methods and compositions for treating ovarian cancer
|
|
US20120183546A1
(en)
|
2009-09-23 |
2012-07-19 |
Amgen Inc. |
Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
|
|
NZ599090A
(en)
|
2009-09-28 |
2014-02-28 |
Hoffmann La Roche |
Benzoxepin pi3k inhibitor compounds and methods of use
|
|
IN2012DN02816A
(enExample)
|
2009-10-08 |
2015-07-24 |
Sanford Burnham Med Res Inst |
|
|
EP2486002B1
(en)
|
2009-10-09 |
2019-03-27 |
Oryzon Genomics, S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
|
US8981084B2
(en)
|
2010-01-13 |
2015-03-17 |
Tempero Pharmaceuticals, Inc. |
Oxadiazole HDAC inhibitors
|
|
SA111320200B1
(ar)
|
2010-02-17 |
2014-02-16 |
ديبيوفارم اس ايه |
مركبات ثنائية الحلقة واستخداماتها كمثبطات c-src/jak مزدوجة
|
|
US8975376B2
(en)
|
2010-02-23 |
2015-03-10 |
Sanofi |
Anti-alpha2 integrin antibodies and their uses
|
|
EP2548017A2
(en)
|
2010-03-15 |
2013-01-23 |
Genus Oncology, Llc |
Small molecule inhibitors of muc1 and methods of identifying the same
|
|
US8927538B2
(en)
|
2010-03-22 |
2015-01-06 |
Council Of Scientific & Industrial Research |
Carbazole linked pyrrolo[2,1-c][1,4]benzodiazefine hybrids as potential anticancer agents and process for the preparation thereof
|
|
MX2012012523A
(es)
|
2010-04-27 |
2012-12-17 |
Pharma Mar Sa |
Lactonas esteroideas anticancerigenas insaturadas en la posicion 7(8).
|
|
EP2566851B1
(en)
|
2010-05-05 |
2015-01-14 |
Universität Bayreuth |
Combretastatin analogs for use in the treatment of cancer
|
|
US8980257B2
(en)
|
2010-05-18 |
2015-03-17 |
Medical & Biological Laboratories Co., Ltd. |
Antibody being capable of binding to transforming growth factor alpha and having growth-suppressing activity on cancers having Ras gene mutation
|
|
HUE044025T2
(hu)
|
2010-05-20 |
2019-09-30 |
Array Biopharma Inc |
Makrociklusos vegyületek mint TRK-kináz inhibitorok
|
|
BR112012033253A2
(pt)
|
2010-06-23 |
2016-11-22 |
Hanmi Science Co Ltd |
novos derivados de pirimidina fundidos para inibição da atividade de tirosina quinase
|
|
WO2012006563A2
(en)
|
2010-07-08 |
2012-01-12 |
The Administrators Of The Tulane Educational Fund |
Novel daidzein analogs as treatment for cancer
|
|
US8975265B2
(en)
|
2010-07-12 |
2015-03-10 |
Bayer Intellectual Property Gmbh |
Substituted imidazo[1,2-a]pyrimidines and —pyridines
|
|
GB201012105D0
(en)
|
2010-07-19 |
2010-09-01 |
Domainex Ltd |
Novel pyrimidine compounds
|
|
US20120171694A1
(en)
|
2010-07-30 |
2012-07-05 |
Vermillion, Inc. |
Predictive markers and biomarker panels for ovarian cancer
|
|
PT2600719E
(pt)
|
2010-08-05 |
2014-12-22 |
Univ Temple |
8 ¿ alquilo -2 - substituído 7 ¿ oxo ¿ 7,8 ¿ diidropirido [2,3 ¿ d] pirimidina ¿ 6 ¿ carbonitrilos e seus usos
|
|
AU2011292044A1
(en)
*
|
2010-08-18 |
2013-04-04 |
Del Mar Pharmaceuticals |
Compositions and methods to improve the therapeutic benefit of suboptimally administered chemical compounds including substituted hexitols such as dianhydrogalactitol and diacetyldianhydrogalactitol
|
|
WO2012027564A1
(en)
|
2010-08-26 |
2012-03-01 |
Millennium Pharmaceuticals, Inc. |
Substituted hydroxamic acids and uses thereof
|
|
ES2537190T3
(es)
|
2010-09-01 |
2015-06-03 |
Gilead Connecticut, Inc. |
Piridazinonas, procedimiento de preparación y procedimientos de utilización de las mismas
|
|
WO2012030685A2
(en)
|
2010-09-01 |
2012-03-08 |
Schering Corporation |
Indazole derivatives useful as erk inhibitors
|
|
US8575191B2
(en)
|
2010-09-01 |
2013-11-05 |
Arqule, Inc. |
Methods for treatment of non-small cell lung cancer
|
|
WO2012037573A1
(en)
|
2010-09-17 |
2012-03-22 |
Indiana University Research And Technology Corporation |
Small molecule inhibitors of replication protein a that also act synergistically with cisplatin
|
|
US8927562B2
(en)
|
2010-09-28 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Fused tricyclic inhibitors of mammalian target of rapamycin
|
|
KR101497113B1
(ko)
|
2010-10-20 |
2015-03-03 |
한국생명공학연구원 |
Ｈｉｆ-1 활성을 저해하는 아릴옥시페녹시아크릴계 화합물, 이의 제조방법 및 이를 유효성분으로 함유하는 약학적 조성물
|
|
AU2011327903A1
(en)
|
2010-11-11 |
2013-05-02 |
Redx Pharma Plc |
Drug derivatives
|
|
SG190245A1
(en)
|
2010-11-12 |
2013-06-28 |
Endocyte Inc |
Methods of treating cancer
|
|
AR083916A1
(es)
|
2010-11-18 |
2013-04-10 |
Takeda Pharmaceutical |
Metodo para tratar el cancer de mama y cancer de ovarios
|
|
AU2011336397B2
(en)
|
2010-12-03 |
2016-12-15 |
Emory University |
Chemokine CXCR4 receptor modulators and uses related thereto
|
|
US8927560B2
(en)
|
2010-12-06 |
2015-01-06 |
Council Of Scientific & Industrial Research |
4-Aza-2, 3-didehydropodophyllotoxin compounds and process for the preparation thereof
|
|
KR20140099556A
(ko)
|
2010-12-16 |
2014-08-12 |
에프. 호프만-라 로슈 아게 |
트라이사이클릭 pi3k 억제제 화합물 및 이의 사용 방법
|
|
WO2012079128A1
(en)
|
2010-12-17 |
2012-06-21 |
Des R Richardson |
Thiosemicarbazone compounds and use in the treatment of cancer
|
|
US8980909B2
(en)
|
2011-01-12 |
2015-03-17 |
Crystal Biopharmaceutical Llc |
HDAC inhibiting derivatives of camptothecin
|
|
RU2591191C2
(ru)
|
2011-01-26 |
2016-07-10 |
НЕРВИАНО МЕДИКАЛ САЙЕНСИЗ С.р.л. |
Трициклические пирроло производные, способ их получения и их применение в качестве ингибиторов киназы
|
|
WO2012103456A2
(en)
|
2011-01-27 |
2012-08-02 |
Board Of Regents, The University Of Texas System |
Polycyclic beta lactam derivatives for the treatment of cancer
|
|
US8987257B2
(en)
|
2011-01-31 |
2015-03-24 |
Novartis Ag |
Heterocyclic derivatives
|
|
WO2012116328A2
(en)
|
2011-02-24 |
2012-08-30 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival
|
|
JP5965923B2
(ja)
|
2011-02-24 |
2016-08-10 |
ジエンス ハンセン ファーマセウティカル カンパニー リミテッド |
プロテインキナーゼ阻害剤としてのリン含有化合物
|
|
GB2503148A
(en)
|
2011-02-24 |
2013-12-18 |
Vermillion Inc |
Biomarker panels diagnostic methods and test kits for ovarian cancer
|
|
EP2681216B1
(en)
|
2011-02-28 |
2017-09-27 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
CA2828326C
(en)
|
2011-03-01 |
2019-05-07 |
Nucana Biomed Limited |
Phosphoramidate derivatives of 5 - fluoro - 2' - deoxyuridine for use in the treatment of cancer
|
|
WO2012119113A2
(en)
|
2011-03-02 |
2012-09-07 |
Nestec Sa |
Prediction of drug sensitivity of lung tumors based on molecular and genetic signatures
|
|
WO2012122059A1
(en)
|
2011-03-04 |
2012-09-13 |
New York University |
Hydrogen bond surrogate macrocycles as modulators of ras
|
|
US8748470B2
(en)
|
2011-03-17 |
2014-06-10 |
The University Of Chicago |
Methods for treating ovarian cancer by inhibiting fatty acid binding proteins
|
|
US20140357605A1
(en)
|
2012-03-22 |
2014-12-04 |
Bristol-Myers Squibb Company |
Bis(fluoroalkyl)-1,4-benzodiazepinone compounds
|
|
US20120269827A1
(en)
|
2011-04-01 |
2012-10-25 |
Immunogen, Inc. |
Compositions and Methods for Treatment of Ovarian, Peritoneal, and Fallopian Tube Cancer
|
|
WO2012138678A1
(en)
|
2011-04-04 |
2012-10-11 |
Merck Sharp & Dohme Corp. |
Gamma secretase inhibitors
|
|
KR20190015600A
(ko)
|
2011-06-24 |
2019-02-13 |
아르퀼 인코포레이티드 |
치환된 이미다조피리디닐-아미노피리딘 화합물
|
|
ME02887B
(me)
|
2011-07-27 |
2018-04-20 |
Astrazeneca Ab |
2-(2,4,5-supstituisani-anilino) pirimidinski derivati kao egfr modulatori korisni za tretman raka
|
|
US9499530B2
(en)
|
2011-08-01 |
2016-11-22 |
Hangzhou Minsheng Institutes For Pharma Research |
Quinazoline derivative, composition having the derivative, and use of the derivative in preparing medicament
|
|
CN103958502B
(zh)
|
2011-08-04 |
2016-02-10 |
阵列生物制药公司 |
作为丝氨酸/苏氨酸激酶抑制剂的喹唑啉化合物
|
|
JP5890524B2
(ja)
|
2011-08-10 |
2016-03-22 |
震 ▲ヤン▼ |
アントロシンの化学合成方法、および非小細胞肺癌を抑制するためのアントロシンの使用
|
|
DE102011112978A1
(de)
|
2011-09-09 |
2013-03-14 |
Merck Patent Gmbh |
Benzonitrilderivate
|
|
PH12014500249A1
(en)
|
2011-09-19 |
2022-11-23 |
Alfasigma Spa |
New thio derivatives bearing lactams as potent hdac inhibitors and their uses as medicaments
|
|
WO2013043255A1
(en)
|
2011-09-21 |
2013-03-28 |
University Of South Alabama |
Methods and compositions for the treatment of ovarian cancer
|
|
JP6014148B2
(ja)
|
2011-09-22 |
2016-10-25 |
メルク・シャープ・アンド・ドーム・コーポレーションＭｅｒｃｋ Ｓｈａｒｐ ＆ Ｄｏｈｍｅ Ｃｏｒｐ． |
ヤヌスキナーゼ阻害剤としてのシクロアルキルニトリルピラゾールカルボキサミド
|
|
TWI547493B
(zh)
|
2011-09-27 |
2016-09-01 |
諾華公司 |
作為突變ｉｄｈ之抑制劑之３－嘧啶－４－基－唑啶－２－酮
|
|
AU2012316084B2
(en)
|
2011-09-28 |
2016-10-27 |
Euro-Celtique S.A. |
Nitrogen mustard derivatives
|
|
US8946445B2
(en)
|
2011-10-12 |
2015-02-03 |
Nanjing Allgen Pharma Co., Ltd. |
Heterocyclic molecules as apoptosis inducers
|
|
CN103958508B
(zh)
|
2011-10-14 |
2019-02-12 |
艾伯维公司 |
用于治疗癌症以及免疫与自身免疫性疾病的细胞凋亡诱导剂
|
|
WO2013062943A1
(en)
|
2011-10-24 |
2013-05-02 |
Glaxosmithkline Intellectual Property Development Limited |
New compounds
|
|
GB201118675D0
(en)
|
2011-10-28 |
2011-12-14 |
Astex Therapeutics Ltd |
New compounds
|
|
GB201118654D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
BR112014010699B1
(pt)
|
2011-11-03 |
2020-12-15 |
Millennium Pharmaceuticals, Inc |
Uso de um inibidor nae com um agente de hipometilação para tratar malignidade hematológica e kit
|
|
JP5976828B2
(ja)
|
2011-11-03 |
2016-08-24 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
Ｂｔｋ活性阻害剤としてのアルキル化ピペラジン化合物
|
|
US9029403B2
(en)
|
2011-11-10 |
2015-05-12 |
Memorial Sloan-Kettering Cancer Center |
Treatment of ovarian cancer with benzylidenebenzohydrazides
|
|
EP2776413A1
(en)
|
2011-11-10 |
2014-09-17 |
Memorial Sloan-Kettering Cancer Center |
TREATMENT OF OVARIAN CANCER WITH 2-AMINO-4H-NAPHTHO[1,2-b]PYRAN-3-CARBONITRILES
|
|
LT2780011T
(lt)
|
2011-11-11 |
2018-05-10 |
Eli Lilly And Company |
Kombinuota kiaušidžių vėžio terapija
|
|
HK1202450A1
(zh)
|
2011-11-22 |
2015-10-02 |
Deciphera Pharmaceuticals, Llc. |
表現出抗癌和抗增殖活性的吡啶酮酰胺以及類似物
|
|
US9376469B2
(en)
|
2011-12-21 |
2016-06-28 |
New York University |
Proteolytically resistant hydrogen bond surrogate helices
|
|
US9260435B2
(en)
|
2012-01-10 |
2016-02-16 |
Bayer Pharma Aktiengesellschaft |
Substituted imidazopyrazines as Akt kinase inhibitors
|
|
CA2860858A1
(en)
|
2012-01-19 |
2013-07-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
WO2013110058A2
(en)
*
|
2012-01-20 |
2013-07-25 |
Bacha Jeffrey |
Use of substituted hexitols including dianhydrogalactitol and analogs to treat neoplastic disease and cancer stem cells including glioblastoma multforme and medulloblastoma
|
|
AU2013216006B2
(en)
|
2012-01-31 |
2017-06-08 |
Daiichi Sankyo Company, Limited |
Pyridone derivatives
|
|
TWI573792B
(zh)
|
2012-02-01 |
2017-03-11 |
歐陸斯迪公司 |
新穎治療劑
|
|
CA2865420C
(en)
|
2012-03-06 |
2020-06-02 |
Cephalon, Inc. |
Fused bicyclic 2,4-diaminopyrimidine derivative as a dual alk and fak inhibitor
|
|
WO2013138665A1
(en)
|
2012-03-16 |
2013-09-19 |
Sanford-Burnham Medical Research Institute |
Inhibitors of furin and other pro-protein convertases
|
|
ES2641864T3
(es)
|
2012-03-20 |
2017-11-14 |
Novartis Ag |
Terapia de combinación de un inhibidor de MEK y un inhibidor de IGF1R
|
|
US10280168B2
(en)
|
2012-03-30 |
2019-05-07 |
Agency For Science, Technology And Research |
Bicyclic heteroaryl derivatives as MNK1 and MNK2 modulators and uses thereof
|
|
KR20140144726A
(ko)
|
2012-03-30 |
2014-12-19 |
리젠 파마슈티컬스 소시에떼 아노님 |
C-met 단백질 키나제의 조절제로서의 신규한 3,5-디치환-3h-이미다조[4,5-b]피리딘 및 3,5- 디치환 -3h-[1,2,3]트리아졸로[4,5-b] 피리딘 화합물
|
|
WO2013152301A1
(en)
|
2012-04-05 |
2013-10-10 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
O-glycan pathway ovarian cancer signature
|
|
CN104379563B
(zh)
|
2012-04-10 |
2018-12-21 |
加利福尼亚大学董事会 |
用于治疗癌症的组合物和方法
|
|
US8975398B2
(en)
|
2012-05-11 |
2015-03-10 |
Abbvie Inc. |
NAMPT inhibitors
|
|
WO2013181462A1
(en)
|
2012-05-31 |
2013-12-05 |
Amgen Inc. |
Use of amg 900 for the treatment of cancer
|
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
|
US8980934B2
(en)
|
2012-06-22 |
2015-03-17 |
University Health Network |
Kinase inhibitors and method of treating cancer with same
|
|
BR112014032346A2
(pt)
*
|
2012-06-26 |
2017-06-27 |
Del Mar Pharmaceuticals |
métodos para tratamento de malignidades resistentes ao inibidor de tirosina-quinase em pacientes com polimorfismos genéticos ou desregulações de ahi1 mutações empregando dianidrogalactitol, diacetildianidrogalactitol, dibromodulcitol, ou análogos ou derivados destes
|
|
WO2014009319A1
(en)
|
2012-07-11 |
2014-01-16 |
Boehringer Ingelheim International Gmbh |
Indolinone derivatives anticancer compounds
|
|
WO2014078295A1
(en)
|
2012-11-13 |
2014-05-22 |
BoYen Therapeutics, Inc. |
Gemcitabine prodrugs and uses thereof
|
|
AR093445A1
(es)
|
2012-11-14 |
2015-06-10 |
Regeneron Pharma |
Metodos para tratar el cancer de ovario con antagonistas de dll4
|
|
US8946246B2
(en)
|
2012-11-16 |
2015-02-03 |
New Mexico Technical Research Foundation |
Synthetic rigidin analogues as anticancer agents, salts, solvates and prodrugs thereof, and method of producing same
|
|
MX2015007205A
(es)
|
2012-12-06 |
2016-03-31 |
Quanticel Pharmaceuticals Inc |
Inhibidores de la desmetilasa de histona.
|
|
BR112015013611A2
(pt)
|
2012-12-20 |
2017-11-14 |
Merck Sharp & Dohme |
composto, e, composição farmacêutica
|
|
EA028774B1
(ru)
|
2012-12-21 |
2017-12-29 |
Квонтисел Фармасьютикалс, Инк. |
Ингибиторы гистондеметилазы
|
|
EP2935243B1
(en)
|
2012-12-21 |
2018-03-14 |
Epizyme, Inc. |
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
|
ES2628156T3
(es)
|
2013-02-14 |
2017-08-01 |
Bristol-Myers Squibb Company |
Compuestos de tubulisina, métodos para su fabricación y su uso
|
|
EP2970285B1
(en)
|
2013-03-11 |
2019-04-17 |
AbbVie Inc. |
Fused tetracyclic bromodomain inhibitors
|
|
BR112015023013A2
(pt)
|
2013-03-13 |
2017-07-18 |
Abbvie Inc |
inibidores de quinase cdk9
|
|
WO2014143241A1
(en)
|
2013-03-15 |
2014-09-18 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
EP2970288A1
(en)
|
2013-03-15 |
2016-01-20 |
Vertex Pharmaceuticals Incorporated |
Compounds useful as inhibitors of atr kinase
|
|
US10413538B2
(en)
|
2013-05-08 |
2019-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Administration of karenitecin for the treatment of platinum and/or taxane chemotherapy-resistant or -refractory advanced ovarian cancer
|
|
US20140371158A1
(en)
|
2013-06-14 |
2014-12-18 |
Georgia Regents University |
Beauvericin compositions and methods thereof for inhibiting the hsp90 chaperone pathway
|
|
AU2014100435A4
(en)
|
2013-06-17 |
2014-05-29 |
Macau University Of Science And Technology |
A novel treatment of Gefitinib-resistant non-small-cell lung cancer
|
|
JP6165977B2
(ja)
|
2013-07-03 |
2017-07-19 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ヘテロアリールピリドン及びアザ−ピリドンアミド化合物
|
|
US9227969B2
(en)
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
|
US9278978B2
(en)
|
2013-08-23 |
2016-03-08 |
Boehringer Ingelheim International Gmbh |
6-Alkynyl Pyridine
|
|
US9249151B2
(en)
|
2013-08-23 |
2016-02-02 |
Boehringer Ingelheim International Gmbh |
Bis-amido pyridines
|
|
US20150065526A1
(en)
|
2013-09-05 |
2015-03-05 |
Emory University |
Overcoming acquired resistance to chemotherapy treatments through suppression of stat3
|
|
US8927717B1
(en)
|
2014-02-14 |
2015-01-06 |
National Defense Medical Center |
Thiochromeno[2,3-c]quinolin-12-one derivatives, preparation method and application thereof
|